These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 22278289)
1. Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells. Kharaziha P; Rodriguez P; Li Q; Rundqvist H; Björklund AC; Augsten M; Ullén A; Egevad L; Wiklund P; Nilsson S; Kroemer G; Grander D; Panaretakis T Cell Death Dis; 2012 Jan; 3(1):e262. PubMed ID: 22278289 [TBL] [Abstract][Full Text] [Related]
2. Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways. Oh SJ; Erb HH; Hobisch A; Santer FR; Culig Z Endocr Relat Cancer; 2012 Jun; 19(3):305-19. PubMed ID: 22383427 [TBL] [Abstract][Full Text] [Related]
3. Sorafenib inhibits STAT3 activation to enhance TRAIL-mediated apoptosis in human pancreatic cancer cells. Huang S; Sinicrope FA Mol Cancer Ther; 2010 Mar; 9(3):742-50. PubMed ID: 20197401 [TBL] [Abstract][Full Text] [Related]
4. Sorafenib sensitizes (-)-gossypol-induced growth suppression in androgen-independent prostate cancer cells via Mcl-1 inhibition and Bak activation. Lian J; Ni Z; Dai X; Su C; Smith AR; Xu L; He F Mol Cancer Ther; 2012 Feb; 11(2):416-26. PubMed ID: 22188816 [TBL] [Abstract][Full Text] [Related]
5. Sorafenib induces growth arrest and apoptosis of human glioblastoma cells through the dephosphorylation of signal transducers and activators of transcription 3. Yang F; Brown C; Buettner R; Hedvat M; Starr R; Scuto A; Schroeder A; Jensen M; Jove R Mol Cancer Ther; 2010 Apr; 9(4):953-62. PubMed ID: 20371721 [TBL] [Abstract][Full Text] [Related]
6. Sorafenib induces growth inhibition and apoptosis in human synovial sarcoma cells via inhibiting the RAF/MEK/ERK signaling pathway. Peng CL; Guo W; Ji T; Ren T; Yang Y; Li DS; Qu HY; Li X; Tang S; Yan TQ; Tang XD Cancer Biol Ther; 2009 Sep; 8(18):1729-36. PubMed ID: 19633425 [TBL] [Abstract][Full Text] [Related]
7. The farnesyl transferase inhibitor lonafarnib inhibits mTOR signaling and enforces sorafenib-induced apoptosis in melanoma cells. Niessner H; Beck D; Sinnberg T; Lasithiotakis K; Maczey E; Gogel J; Venturelli S; Berger A; Mauthe M; Toulany M; Flaherty K; Schaller M; Schadendorf D; Proikas-Cezanne T; Schittek B; Garbe C; Kulms D; Meier F J Invest Dermatol; 2011 Feb; 131(2):468-79. PubMed ID: 20944654 [TBL] [Abstract][Full Text] [Related]
8. Combined inhibition of MAPK and mTOR signaling inhibits growth, induces cell death, and abrogates invasive growth of melanoma cells. Lasithiotakis KG; Sinnberg TW; Schittek B; Flaherty KT; Kulms D; Maczey E; Garbe C; Meier FE J Invest Dermatol; 2008 Aug; 128(8):2013-23. PubMed ID: 18323781 [TBL] [Abstract][Full Text] [Related]
9. Sorafenib combined vitamin K induces apoptosis in human pancreatic cancer cell lines through RAF/MEK/ERK and c-Jun NH2-terminal kinase pathways. Wei G; Wang M; Carr BI J Cell Physiol; 2010 Jul; 224(1):112-9. PubMed ID: 20301194 [TBL] [Abstract][Full Text] [Related]
10. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines. Ulivi P; Arienti C; Amadori D; Fabbri F; Carloni S; Tesei A; Vannini I; Silvestrini R; Zoli W J Cell Physiol; 2009 Jul; 220(1):214-21. PubMed ID: 19288493 [TBL] [Abstract][Full Text] [Related]
12. The multikinase inhibitor sorafenib potentiates TRAIL lethality in human leukemia cells in association with Mcl-1 and cFLIPL down-regulation. Rosato RR; Almenara JA; Coe S; Grant S Cancer Res; 2007 Oct; 67(19):9490-500. PubMed ID: 17909059 [TBL] [Abstract][Full Text] [Related]
13. Sorafenib induces apoptosis and autophagy in prostate cancer cells in vitro. Ullén A; Farnebo M; Thyrell L; Mahmoudi S; Kharaziha P; Lennartsson L; Grandér D; Panaretakis T; Nilsson S Int J Oncol; 2010 Jul; 37(1):15-20. PubMed ID: 20514392 [TBL] [Abstract][Full Text] [Related]
14. Sorafenib-induced apoptosis of chronic lymphocytic leukemia cells is associated with downregulation of RAF and myeloid cell leukemia sequence 1 (Mcl-1). Fecteau JF; Bharati IS; O'Hayre M; Handel TM; Kipps TJ; Messmer D Mol Med; 2012 Feb; 18(1):19-28. PubMed ID: 21979753 [TBL] [Abstract][Full Text] [Related]
15. The monoclonal antibody CH12 enhances the sorafenib-mediated growth inhibition of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III. Yang Y; Jiang H; Gao H; Kong J; Zhang P; Hu S; Shi B; Zhang P; Yao M; Li Z Neoplasia; 2012 Jun; 14(6):509-18. PubMed ID: 22787432 [TBL] [Abstract][Full Text] [Related]
16. Vitamin K enhancement of sorafenib-mediated HCC cell growth inhibition in vitro and in vivo. Wei G; Wang M; Hyslop T; Wang Z; Carr BI Int J Cancer; 2010 Dec; 127(12):2949-58. PubMed ID: 21351273 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of Bcl-2 antiapoptotic members by obatoclax potently enhances sorafenib-induced apoptosis in human myeloid leukemia cells through a Bim-dependent process. Rahmani M; Aust MM; Attkisson E; Williams DC; Ferreira-Gonzalez A; Grant S Blood; 2012 Jun; 119(25):6089-98. PubMed ID: 22446485 [TBL] [Abstract][Full Text] [Related]
18. Sorafenib inhibits signal transducer and activator of transcription 3 signaling associated with growth arrest and apoptosis of medulloblastomas. Yang F; Van Meter TE; Buettner R; Hedvat M; Liang W; Kowolik CM; Mepani N; Mirosevich J; Nam S; Chen MY; Tye G; Kirschbaum M; Jove R Mol Cancer Ther; 2008 Nov; 7(11):3519-26. PubMed ID: 19001435 [TBL] [Abstract][Full Text] [Related]
19. Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma. Ou DL; Shen YC; Liang JD; Liou JY; Yu SL; Fan HH; Wang DS; Lu YS; Hsu C; Cheng AL Clin Cancer Res; 2009 Sep; 15(18):5820-8. PubMed ID: 19737956 [TBL] [Abstract][Full Text] [Related]
20. Sorafenib inhibits ERK1/2 and MCL-1(L) phosphorylation levels resulting in caspase-independent cell death in malignant pleural mesothelioma. Katz SI; Zhou L; Chao G; Smith CD; Ferrara T; Wang W; Dicker DT; El-Deiry WS Cancer Biol Ther; 2009 Dec; 8(24):2406-16. PubMed ID: 20038816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]